The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Mean Change in PTSD Symptoms - Clinician Administered PTSD Scale for DSM-5 - Child/Adolescent Version (CAPS-CA)
Timeframe: Baseline (pre-treatment), Week 19 (post-treatment)
Mean Change in PTSD Symptoms - Child PTSD Symptom Scale for DSM-5 (CPSS)
Timeframe: Baseline (pre-treatment), Week 19 (post-treatment)
Mean Change in PTSD Symptoms - Child and Adolescent Trauma Screen (CATS-2)
Timeframe: Baseline (pre-treatment), Week 19 (post-treatment)